Emerging Cannabinoid Products in Europe: Transparency, Testing and Regulatory Challenges in 2026
Alongside established CBD products, consumers are increasingly encountering new commercial names, new formulations and products positioned around recently introduced cannabinoids. This creates a basic problem for both retailers and buyers: a commercial name does not necessarily tell the consumer what a substance is, how it was produced or how […]
